Skip to contentApplication 202941
- Type
- ANDA
- Sponsor
- APOTEX
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | LAMIVUDINE | LAMIVUDINE | TABLET;ORAL | 100MG | No | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 60505-3250 | Lamivudine | Lamivudine | Apotex Corp. | ANDA | Current |
| 60505-3250 | Lamivudine | Lamivudine | Apotex Corp. | ANDA | Current |
| 60505-3250 | Lamivudine | Lamivudine | Apotex Corp. | ANDA | Current |
Documents#
Document, Submission type, Date table| Document | Submission type | Date |
|---|
| 40241 | ORIG | 2014-01-13 |
| 32340 | ORIG | 2014-01-03 |